BioSpace News Archive

Business

HALO Precision Diagnostics Appoints Thomas P. Slavin, M.D., as Chief Scientific Officer

HALO Precision Diagnostics (“HALO”), a leader in early disease detection using precision diagnostics, today announced the appointment of Thomas P. Slavin, M.D., as chief scientific officer.

October 12, 2023
·
3 min read
Pharm Country

The Mark Foundation for Cancer Research Teams Up with Takeda to Fund Groundbreaking Research to Uncover and Target Novel Cancer Vulnerabilities

The Mark Foundation for Cancer Research announced an alliance with Takeda to accelerate the discovery and development of novel treatments for cancer.

October 12, 2023
·
4 min read
BioMidwest

HealthPlan Data Solutions Presents Positive Results of New Pharmacy Payment Integrity Program at Kentucky Legislature’s Interim Joint Committee on Health Services

On September 27, 2023, HealthPlan Data Solutions (HDS) executives presented initial results from its pharmacy payment integrity program implemented with the Kentucky Employees’ Health Plan (KEHP) during an Interim Joint Committee meeting on Health Services.

October 12, 2023
·
3 min read
Edesa Biotech to Receive Up To C$23 Million in Funding from Federal Government

Edesa Biotech, Inc. has secured a commitment of up to C$23 million from the Government of Canada for a pivotal Phase 3 clinical study of the company’s first-in-class therapeutic candidate.

October 12, 2023
·
7 min read
Edesa Biotech Secures $10 Million Credit Facility with Company Founder

Edesa Biotech, Inc. announced it has entered into a binding commitment letter in respect of a $10 million revolving credit facility agreement with Dr. Par Nijhawan, MD, the Company’s Chief Executive Officer and Founder.

October 12, 2023
·
6 min read
Business

InMode Expects Third Quarter 2023 Revenue Between $122.8M-$123.0M, Lowering Full-Year 2023 Revenue Guidance to $500M-$510M vs. Original Estimates of $530M-$540M

InMode Ltd., a leading global provider of innovative medical technologies, announced that it expects to release its financial results for the third quarter of 2023 before the Nasdaq market opens on Thursday, Nov. 2, 2023.

October 12, 2023
·
6 min read
Business

Sun Scientific Welcomes Jeff Schultz as Vice President of Sales, North America, Effective October 2, 2023

Sun Scientific, an innovative provider of compression and wound care solutions, is pleased to announce the appointment of Jeff Schultz as the new Vice President of Sales, North America.

October 12, 2023
·
1 min read
Pharm Country

Amneal Adds Two Denosumab Biosimilars to U.S. Pipeline, Expanding Oncology Portfolio

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced the addition of two denosumab biosimilars referencing both Prolia ® and XGEVA ® to its biosimilar pipeline.

October 12, 2023
·
7 min read
BioForest

AGC Biologics Completes pDNA and mRNA Line Expansion in Heidelberg

AGC Biologics today announced the completion of the facility expansion for its new plasmid DNA (pDNA) and messenger RNA (mRNA) production line at the CDMO’s Heidelberg, Germany site.

October 12, 2023
·
3 min read
Business

DermTech Announces Release Date for Third-Quarter 2023 Financial Results

DermTech, Inc. will host a conference call and webcast on Thursday, November 2, 2023 at 5:00 p.m. Eastern Time (ET) to discuss the Company’s third-quarter 2023 operating and financial results.

October 12, 2023
·
4 min read